Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-16-001107
Filing Date
2016-08-10
Accepted
2016-08-10 16:50:19
Documents
52
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q appy_10q-063016.htm 10-Q 499669
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 11541
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 9948
4 EXHIBIT 32 ex32.htm EX-32 7280
11 image24.jpg GRAPHIC 33267
  Complete submission text file 0001079973-16-001107.txt   2890210

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT appy-20160630.xml EX-101.INS 479351
6 XBRL TAXONOMY EXTENSION SCHEMA appy-20160630.xsd EX-101.SCH 28824
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20160630_cal.xml EX-101.CAL 43062
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appy-20160630_def.xml EX-101.DEF 102769
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20160630_lab.xml EX-101.LAB 269241
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20160630_pre.xml EX-101.PRE 197245
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 161822045
SIC: 2835 In Vitro & In Vivo Diagnostic Substances